Top

Journal of Clinical Immunology

Published in:

01-02-2018 | Letter to Editor

Serum Free Light Chains in CVID—a Marker for Differential Diagnosis

Authors: Leif G. Hanitsch, Franziska Sotzny, Hans-Dieter Volk, Carmen Scheibenbogen, Kirsten Wittke

Published in: Journal of Clinical Immunology | Issue 2/2018

Excerpt

To the Editor: …

Available only for authorised users

Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program. 2012;2012:301–5. https://doi.org/10.1182/asheducation-2012.1.301.PubMedPubMedCentral

Compagno N, Cinetto F, Boscaro E, Semenzato G, Agostini C. Serum free light chains in the differential diagnosis and prognosis of primary and secondary hypogammaglobulinemia. J Allergy Clin Immunol. 2015;135(4):1075–7 e6. https://doi.org/10.1016/j.jaci.2014.10.003.CrossRefPubMed

Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol. 2008;128(3):314–21. https://doi.org/10.1016/j.clim.2008.02.013.CrossRefPubMedPubMedCentral

Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 2005;115(2):412–7. https://doi.org/10.1016/j.jaci.2004.10.048.CrossRefPubMed

Schussler E, Beasley MB, Maglione PJ. Lung disease in primary antibody deficiencies. J Allergy Clin Immunol Pract. 2016;4(6):1039–52. https://doi.org/10.1016/j.jaip.2016.08.005.CrossRefPubMedPubMedCentral

Title: Serum Free Light Chains in CVID—a Marker for Differential Diagnosis
Authors: Leif G. Hanitsch
Franziska Sotzny
Hans-Dieter Volk
Carmen Scheibenbogen
Kirsten Wittke
Publication date: 01-02-2018
Publisher: Springer US
Published in: Journal of Clinical Immunology / Issue 2/2018
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-018-0478-y

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Serum Free Light Chains in CVID—a Marker for Differential Diagnosis

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2018

Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency

Ralph Josiah Patrick Wedgwood (1924–2017)

IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation

Impact of Using Different Response Criteria for Pneumococcal Polysaccharide Vaccination for Assessment of Humoral Immune Status

Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland

Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page